Literature DB >> 18363353

Proteomic analysis of amniotic fluid in pregnancies with Turner syndrome fetuses.

Ariadni Mavrou1, Athanasios K Anagnostopoulos, Aggeliki Kolialexi, Konstantinos Vougas, Nikos Papantoniou, Aris Antsaklis, Michael Fountoulakis, George Th Tsangaris.   

Abstract

Turner syndrome, occurring in 1:2500 female births, is caused by the complete or partial absence of one X chromosome. Amniotic fluid supernatant proteins from five second trimester pregnancies with Turner syndrome fetuses and five normal ones were analyzed by 2DE, MALDI-TOF-MS, and Western blot. Serotransferin, lumican, plasma retinol-binding protein, and apolipoprotein A-I were increased in Turner syndrome, while kininogen, prothrombin, and apolipoprotein A-IV were decreased. Since differentially expressed proteins are likely to cross the placenta barrier and be detected in maternal plasma, proteomic analysis may enhance research for noninvasive prenatal diagnosis of Turner syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363353     DOI: 10.1021/pr700588u

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  9 in total

1.  High-throughput discovery and characterization of fetal protein trafficking in the blood of pregnant women.

Authors:  Jill L Maron; Gil Alterovitz; Marco Ramoni; Kirby L Johnson; Diana W Bianchi
Journal:  Proteomics Clin Appl       Date:  2009-12       Impact factor: 3.494

Review 2.  The Use of Proteomics in Assisted Reproduction.

Authors:  Ioanna Kosteria; Athanasios K Anagnostopoulos; Christina Kanaka-Gantenbein; George P Chrousos; George T Tsangaris
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

3.  2D DIGE analysis of maternal plasma for potential biomarkers of Down Syndrome.

Authors:  Wendy E Heywood; Tracey E Madgett; Darrell Wang; Amanda Wallington; Julie Hogg; Kevin Mills; Neil D Avent
Journal:  Proteome Sci       Date:  2011-09-19       Impact factor: 2.480

4.  Quantitative proteomic analysis of serum from pregnant women carrying a fetus with conotruncal heart defect using isobaric tags for relative and absolute quantitation (iTRAQ) labeling.

Authors:  Ying Zhang; Yuan Kang; Qiongjie Zhou; Jizi Zhou; Huijun Wang; Hong Jin; Xiaohui Liu; Duan Ma; Xiaotian Li
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

5.  Human coelomic fluid investigation: A MS-based analytical approach to prenatal screening.

Authors:  Donatella Aiello; Antonino Giambona; Filippo Leto; Cristina Passarello; Gianfranca Damiani; Aurelio Maggio; Carlo Siciliano; Anna Napoli
Journal:  Sci Rep       Date:  2018-07-20       Impact factor: 4.379

6.  IgGFc-binding protein in pregnancies complicated by spontaneous preterm delivery: a retrospective cohort study.

Authors:  Jaroslav Stranik; Marian Kacerovsky; Ondrej Soucek; Martina Kolackova; Ivana Musilova; Lenka Pliskova; Radka Bolehovska; Pavel Bostik; Jana Matulova; Bo Jacobsson; Ctirad Andrys
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

7.  The amniotic fluid proteome changes with gestational age in normal pregnancy: a cross-sectional study.

Authors:  Gaurav Bhatti; Roberto Romero; Nardhy Gomez-Lopez; Tinnakorn Chaiworapongsa; Eunjung Jung; Francesca Gotsch; Roger Pique-Regi; Percy Pacora; Chaur-Dong Hsu; Mahendra Kavdia; Adi L Tarca
Journal:  Sci Rep       Date:  2022-01-12       Impact factor: 4.996

8.  Comparative Proteomic Assessment of Normal vs. Polyhydramnios Amniotic Fluid Based on Computational Analysis.

Authors:  Rūta Navakauskienė; Sandra Baronaitė; Dalius Matuzevičius; Natalija Krasovskaja; Gražina Treigytė; Audronė Arlauskienė; Dalius Navakauskas
Journal:  Biomedicines       Date:  2022-07-28

9.  Application of proteomics for the identification of biomarkers in amniotic fluid: are we ready to provide a reliable prediction?

Authors:  George Th Tsangaris; Athanasios K Anagnostopoulos; Georgia Tounta; Aris Antsaklis; Ariadni Mavrou; Aggeliki Kolialexi
Journal:  EPMA J       Date:  2011-06-19       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.